Orgenesis Inc. (ORGS)
NASDAQ: ORGS · IEX Real-Time Price · USD
0.507
-0.006 (-1.13%)
At close: Apr 26, 2024, 4:00 PM
0.512
+0.005 (0.97%)
After-hours: Apr 26, 2024, 6:00 PM EDT

Orgenesis Revenue

In the year 2023, Orgenesis had annual revenue of $530.00K, a decrease of -98.53%. Revenue in the quarter ending December 31, 2023 was $165.00K, a -98.79% decrease year-over-year.

Revenue (ttm)
$530.00K
Revenue Growth
-98.53%
P/S Ratio
32.86
Revenue / Employee
$3,630
Employees
146
Market Cap
17.41M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023530.00K-35.50M-98.53%
Dec 31, 202236.03M523.00K1.47%
Dec 31, 202135.50M27.85M363.96%
Dec 31, 20207.65M3.75M96.26%
Dec 31, 20193.90M-14.76M-79.10%
Nov 30, 201818.66M8.57M84.90%
Nov 30, 201710.09M3.69M57.71%
Nov 30, 20166.40M3.42M115.10%
Nov 30, 20152.97M--
Nov 30, 20140--
Nov 30, 20130--
Nov 30, 20120--
Nov 30, 20110--
Nov 30, 20100--
Nov 30, 20090--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ATI Physical Therapy 699.02M
CareCloud 117.06M
VBI Vaccines 8.68M
PAVmed 2.45M
Akso Health Group 2.20M
Talis Biomedical 2.13M
Benitec Biopharma 61.00K
Revenue Rankings